How Gene Editing Therapies Could Go Beyond Rare Diseases
Rahman Oladigbolu, a 52-year-old Harvard-educated film maker with sickle cell disease, poses for a ... [+] photo. Born in Nigeria, he is very interested in Casgevy, the CRISPR-based sickle cell treatment that was recently approved by the FDA. He has had …